Literature DB >> 26276162

Some Ethical Concerns About Human Induced Pluripotent Stem Cells.

Yue Liang Zheng1.   

Abstract

Human induced pluripotent stem cells can be obtained from somatic cells, and their derivation does not require destruction of embryos, thus avoiding ethical problems arising from the destruction of human embryos. This type of stem cell may provide an important tool for stem cell therapy, but it also results in some ethical concerns. It is likely that abnormal reprogramming occurs in the induction of human induced pluripotent stem cells, and that the stem cells generate tumors in the process of stem cell therapy. Human induced pluripotent stem cells should not be used to clone human beings, to produce human germ cells, nor to make human embryos. Informed consent should be obtained from patients in stem cell therapy.

Entities:  

Keywords:  Ethical concerns; Human cloning; Human embryo; Human germ cell; Human induced pluripotent stem cells; Informed consent; Reprogramming; Tumorigenicity

Mesh:

Year:  2015        PMID: 26276162     DOI: 10.1007/s11948-015-9693-6

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  17 in total

1.  Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.

Authors:  Frank Soldner; Josée Laganière; Albert W Cheng; Dirk Hockemeyer; Qing Gao; Raaji Alagappan; Vikram Khurana; Lawrence I Golbe; Richard H Myers; Susan Lindquist; Lei Zhang; Dmitry Guschin; Lauren K Fong; B Joseph Vu; Xiangdong Meng; Fyodor D Urnov; Edward J Rebar; Philip D Gregory; H Steve Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2011-07-14       Impact factor: 41.582

2.  Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

Authors:  Frank Soldner; Dirk Hockemeyer; Caroline Beard; Qing Gao; George W Bell; Elizabeth G Cook; Gunnar Hargus; Alexandra Blak; Oliver Cooper; Maisam Mitalipova; Ole Isacson; Rudolf Jaenisch
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

3.  Generation of eggs from mouse embryonic stem cells and induced pluripotent stem cells.

Authors:  Katsuhiko Hayashi; Mitinori Saitou
Journal:  Nat Protoc       Date:  2013-07-11       Impact factor: 13.491

4.  iPS cells can support full-term development of tetraploid blastocyst-complemented embryos.

Authors:  Lan Kang; Jianle Wang; Yu Zhang; Zhaohui Kou; Shaorong Gao
Journal:  Cell Stem Cell       Date:  2009-07-23       Impact factor: 24.633

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

6.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

7.  A high-efficiency system for the generation and study of human induced pluripotent stem cells.

Authors:  Nimet Maherali; Tim Ahfeldt; Alessandra Rigamonti; Jochen Utikal; Chad Cowan; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

8.  Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice.

Authors:  Katsuhiko Hayashi; Sugako Ogushi; Kazuki Kurimoto; So Shimamoto; Hiroshi Ohta; Mitinori Saitou
Journal:  Science       Date:  2012-10-04       Impact factor: 47.728

9.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

10.  iPS cells produce viable mice through tetraploid complementation.

Authors:  Xiao-yang Zhao; Wei Li; Zhuo Lv; Lei Liu; Man Tong; Tang Hai; Jie Hao; Chang-long Guo; Qing-wen Ma; Liu Wang; Fanyi Zeng; Qi Zhou
Journal:  Nature       Date:  2009-09-03       Impact factor: 49.962

View more
  8 in total

1.  Mass Production of Human "Embryoid" Cells from Developmentally Frozen Embryos: Is It Ethical?

Authors:  Patrick Pullicino; Edward J Richard; William J Burke
Journal:  Linacre Q       Date:  2020-05-22

Review 2.  Generation of defined neural populations from pluripotent stem cells.

Authors:  Sarah F McComish; Maeve A Caldwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

Review 3.  Characterization of Tendon-Derived Stem Cells and Rescue Tendon Injury.

Authors:  Bing Wei; Jun Lu
Journal:  Stem Cell Rev Rep       Date:  2021-03-02       Impact factor: 5.739

Review 4.  From the perspective of embryonic tendon development: various cells applied to tendon tissue engineering.

Authors:  Fangjie Qi; Zhantao Deng; Yuanchen Ma; Shuai Wang; Chang Liu; Fengjuan Lyu; Tao Wang; Qiujian Zheng
Journal:  Ann Transl Med       Date:  2020-02

Review 5.  Applications of mesenchymal stem cell technology in bovine species.

Authors:  Amanda Baracho Trindade Hill; Fabiana Fernandes Bressan; Bruce D Murphy; Joaquim Mansano Garcia
Journal:  Stem Cell Res Ther       Date:  2019-01-24       Impact factor: 6.832

Review 6.  Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models.

Authors:  Angeliki Spathopoulou; Frank Edenhofer; Lisa Fellner
Journal:  Front Neurol       Date:  2022-01-25       Impact factor: 4.003

Review 7.  Concise Review: Stem Cell Models of SCN1A-Related Encephalopathies-Current Perspective and Future Therapies.

Authors:  Valery Zayat; Roza Szlendak; Dorota Hoffman-Zacharska
Journal:  Cells       Date:  2022-10-04       Impact factor: 7.666

Review 8.  Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs).

Authors:  Marcin Orzechowski; Maximilian Schochow; Michael Kühl; Florian Steger
Journal:  Stem Cell Res Ther       Date:  2020-03-19       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.